Table 3.

Relative contribution of dentistry-related antimicrobial use to the total ambulatory use in Belgium (2016)

Antimicrobial product	Dentistry-related use (DID)	Total use in ambulatory setting (DID)	Proportion dentistry-related use to total ambulatory use (%)*
Amoxicillin (J01CA04)	0.789	7.510	10.5
Amoxicillin + enzyme inhibitor (J01CR02)	0.620	7.380	8.4
Clindamycin (J01FF01)	0.075	0.373	20.1
Clarithromycin (J01FA09)	0.039	1.410	2.8
Doxycycline (J01AA02)	0.031	0.754	4.1
Azithromycin (J01FA10)	0.027	1.770	1.5
Metronidazole (P01AB01)	0.014	0.123	11.6
Spiramycin (J01FA02)	0.005	0.020	26.4
Cefuroxime (J01DC02)	0.005	1.240	0.4
Nitrofurantoin (J01XE01)	0.003	1.550	0.2
Phenoxymethylpenicillin (J01CE02)	0.0001	0.026	0.3
Other	0.013	5.354	0.2
Antibacterials for systemic use (J01)	1.607	27.510	5.8
Antiprotozoals (P01AB)	0.014	1.1340	10.7
Total	1.621	28.644	5.7

^*Calculated as: DID in column one divided by the DID in column two, multiplied by 100.

DID, defined daily dose (DDDs) per 1,000 inhabitants per day.